Skip to content

The Use of Cooling Helmet for Neuroprotection Management in Open Heart Surgery

The Use of Cooling Helmet for Neuroprotection Management in Patient Undergoing Open Heart Surgery: an Evaluation of Postoperative Neuron-specific Enolase (NSE) and Delirium

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05264766
Enrollment
26
Registered
2022-03-03
Start date
2021-10-01
Completion date
2021-12-31
Last updated
2022-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart; Surgery, Heart, Functional Disturbance as Result

Keywords

cooling helmet, neuron specific enolase, delirium, open heart surgery

Brief summary

To know the relationship between the use of cooling helmet with the changes of NSE level and postoperative delirium event in open heart surgery

Detailed description

Subjects were assigned into two groups after giving consent to participate in the study using random allocation, 13 subjects per group. Blood sample from CVC were obtained to assess NSE preoperative. After induction, cooling helmet with circulating cold water were placed on patients group A and without circulating cold water on group B. Blood samples were obtain again 6 hours after cardiopulmonary bypass off to assess NSE postoperative. Delirium was assessed using Confusion Assessment Method - Intensive Care Unit (CAM-ICU)

Interventions

DEVICECooling helmet on

Cooling helmet with circulating cold water

DEVICECooling helmet off

Cooling helmet without circulating cold water

Sponsors

Indonesia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient undergoing their first open heart surgery using cardiopulmonary bypass * Age ≥18 year-old * Patient with American Society of Anesthesiologists (ASA) III * Patient with Glasgow Coma Scale (GCS) 15, fully aware and oriented * Patient fluent in Indonesia

Exclusion criteria

* Patients did not give consent to participate in the study * Patients with central nervous system disease (stroke, intracranial tumor) * Patients with psychiatric problem (schizophrenia, depression) * Patients with cognitive problem * Blind and deaf patient * Patient on psychotrophic or narcotics medication Drop out criteria * Surgery without cardiopulmonary bypass * Patient demise after surgery * Patients decided to refrain from the study

Design outcomes

Primary

MeasureTime frameDescription
Neuron-specific enolase6 hours post cardiopulmonary bypass offNeuronal injury marker. The higher the value, the worse the outcome
Confusion Assessment Method - Intensive Care Unit (CAM-ICU)Changes of CAM-ICU from 12 hours to 24 hours postoperativeTools to assess delirium. The higher the errors, the worse the outcome

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026